VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $234,286 | +9.7% | 9,551 | +4.1% | 0.06% | +1.8% |
| Q1 2023 | $213,572 | -8.1% | 9,178 | 0.0% | 0.06% | -9.5% |
| Q4 2022 | $232,295 | -23.8% | 9,178 | +26.1% | 0.06% | -1.6% |
| Q1 2022 | $305,000 | 0.0% | 7,276 | 0.0% | 0.06% | +12.3% |
| Q4 2021 | $305,000 | +34.4% | 7,276 | +39.3% | 0.06% | +23.9% |
| Q3 2021 | $227,000 | – | 5,225 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |